SBC Medical Group Holdings Incorporated (Nasdaq: SBC) announced its financial results for the third quarter of fiscal year 2026, reporting a 35% increase in total revenues to $59 million. The company reported income from operations of $26 million, representing a 66% year-over-year increase and an operating margin of 45%. Net income attributable to SBC Medical increased 22% year-over-year to $16 million, resulting in a net income margin of 27%.
Adjusted EBITDA for the quarter was $28 million, up 66% from the prior year, with a margin of 47%. Basic earnings per share (EPS) rose 25% year-over-year to $0.15. The company noted that revenue growth was driven by higher management services revenue, including the impact of service fee structure revisions announced in August, as well as the consolidation of Waqoo.
As of September 30, 2026, the company’s clinic network consisted of 293 locations, an increase of 36 locations year-over-year. Patient visits over the trailing twelve months totaled 7.06 million, up 9% year-over-year. Average spend per visit was $290, up 4% year-over-year.
For the nine months ended September 30, 2026, total revenues were $151 million, up 13% year-over-year. Net income attributable to SBC Medical for the nine months was $38 million, and Adjusted EBITDA was $66 million.
As of September 30, 2026, the company held $198 million in cash and cash equivalents and $154 million in Net Cash. The company plans to use its strong financial position to fund disciplined growth investments.
